Study finds CDK4/6 plus EGFR blockade kills pancreatic cancer cells without KRAS drugs

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS ...
News Medical

Novel approach improves the efficacy of immune checkpoint blockade and minimizes related ...

Scientists at Tohoku University have discovered a novel approach that improves the efficacy of immune checkpoint blockade (ICB) - a novel form of cancer treatment utilizing immune checkpoint ...